Form 4 holding
EVP & General Counsel
CVS HEALTH Corp
- Security class
- Common Stock
- Shares / value
- 315,273
- Estimated value
- $23,418,480
- Report date
- 31 Dec 2022
- Price
- $74.28
- Ownership
- Direct
Thomas M. Moriarty
Insider Reports History
- Reporting-owner location
- Franklin Lakes, NJ
- Latest reporting-owner signature
-
/s/ Thomas Moriarty
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Thomas M. Moriarty
Form 4 holding
EVP & General Counsel
CVS HEALTH Corp
- Security class
- Common Stock
- Shares / value
- 159,120
- Estimated value
- $11,819,434
- Report date
- 31 Dec 2022
- Price
- $74.28
- Ownership
- By GRAT
Form 4 holding
EVP, M&A and Corporate Affairs
Albertsons Companies, Inc.
- Security class
- Class A common stock, par value $0.01
- Shares / value
- 308,946
- Estimated value
- $4,180,039
- Report date
- 07 Aug 2026
- Price
- $13.53
- Ownership
- By Family Trust
Form 4 holding
EVP, M&A and Corporate Affairs
Albertsons Companies, Inc.
- Security class
- Class A common stock, par value $0.01
- Shares / value
- 308,946
- Estimated value
- $3,555,659
- Report date
- 27 Jul 2026
- Price
- $11.51
- Ownership
- Direct
Form 4 holding
EVP & General Counsel
CVS HEALTH Corp
- Security class
- Stock Option
- Shares / value
- 46,777
- Estimated value
- $3,178,497
- Report date
- 31 Dec 2022
- Price
- $67.95
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 46,777
Form 4 holding
EVP, M&A and Corporate Affairs
Albertsons Companies, Inc.
- Security class
- Time-based Restricted Stock Units
- Shares / value
- 109,957
- Estimated value
- $3,043,985
- Report date
- 16 Apr 2026
- Price
- $18.10
- Ownership
- Direct
- Underlying class
- Class A common stock par value $0.01
- Underlying amount
Form 4 holding
EVP, M&A and Corporate Affairs
Albertsons Companies, Inc.
- Security class
- Dividend Equivalent Units
- Shares / value
- 112,697
- Estimated value
- $598,796
- Report date
- 07 Aug 2026
- Price
- $19.58
- Ownership
- Direct
- Underlying class
- Time-based Restricted StockUnits
- Underlying amount
Form 4 holding
EVP, M&A and Corporate Affairs
Albertsons Companies, Inc.
- Security class
- Performance-Based Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $500,229
- Report date
- 21 Apr 2026
- Price
- $18.10
- Ownership
- Direct
- Underlying class
- Class A common stock, par value $0.01
- Underlying amount
Form 4 holding
EVP & General Counsel
CVS HEALTH Corp
- Security class
- Stock Unit
- Shares / value
- 47,325
- Estimated value
- Report date
- 31 Dec 2022
- Price
- Ownership
- Direct
Form 4 holding
EVP, M&A and Corporate Affairs
Albertsons Companies, Inc.
- Security class
- Class A common stock, par value $0.01
- Shares / value
- 45,725
- Estimated value
- Report date
- 21 Apr 2026
- Price
- Ownership
- Family Trust
Insider Reports Filed by Thomas M. Moriarty
4
ACI
Albertsons Companies, Inc.
- Report period
- 07 Aug 2026
- Transactions
- 5
- Transaction value
- $0
- Accepted by SEC
- 11 Aug 2026, 18:00
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 27 Jul 2026
- Transactions
- 1
- Transaction value
- +$1,962,284
- Accepted by SEC
- 28 Jul 2026, 19:29
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 08 May 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 12 May 2026, 21:59
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 21 Apr 2026
- Transactions
- 9
- Transaction value
- $0
- Accepted by SEC
- 23 Apr 2026, 18:37
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 16 Apr 2026
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 20 Apr 2026, 19:43
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 02 Mar 2026
- Transactions
- 9
- Transaction value
- $0
- Accepted by SEC
- 04 Mar 2026, 21:22
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 06 Feb 2026
- Transactions
- 7
- Transaction value
- $0
- Accepted by SEC
- 10 Feb 2026, 19:36
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4/A
ACI
Albertsons Companies, Inc.
- Report period
- 01 Dec 2025
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 09 Apr 2026, 18:17
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 01 Dec 2025
- Transactions
- 16
- Transaction value
- -$431,052
- Accepted by SEC
- 04 Dec 2025, 08:43
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 07 Nov 2025
- Transactions
- 7
- Transaction value
- $0
- Accepted by SEC
- 10 Nov 2025, 19:56
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 08 Aug 2025
- Transactions
- 7
- Transaction value
- $0
- Accepted by SEC
- 12 Aug 2025, 16:39
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 09 May 2025
- Transactions
- 6
- Transaction value
- $0
- Accepted by SEC
- 13 May 2025, 18:06
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4/A
ACI
Albertsons Companies, Inc.
- Report period
- 01 May 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 13 Jun 2025, 18:40
- Role
- EVP, M&A and Corporate Affairs
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 17 Apr 2025
- Transactions
- 4
- Transaction value
- $0
- Accepted by SEC
- 25 Apr 2025, 21:04
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 24 Feb 2025
- Transactions
- 6
- Transaction value
- +$644,366
- Accepted by SEC
- 26 Feb 2025, 21:27
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 07 Feb 2025
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 11 Feb 2025, 19:09
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 08 Nov 2024
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 12 Nov 2024, 18:04
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 09 Aug 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 13 Aug 2024, 18:07
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 10 May 2024
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 14 May 2024, 19:59
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 24 Apr 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 26 Apr 2024, 20:06
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 26 Feb 2024
- Transactions
- 3
- Transaction value
- -$272,374
- Accepted by SEC
- 27 Feb 2024, 21:20
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 09 Feb 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 13 Feb 2024, 19:24
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 14 Nov 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 15 Nov 2023, 17:25
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 10 Aug 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 14 Aug 2023, 20:53
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
ACI
Albertsons Companies, Inc.
- Report period
- 03 Jul 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 06 Jul 2023, 10:47
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
3
ACI
Albertsons Companies, Inc.
- Report period
- 12 Jun 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Jun 2023, 16:14
- Role
- EVP General Counsel & CPO
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 31 Dec 2022
- Transactions
- 1
- Transaction value
- -$27,291,251
- Accepted by SEC
- 04 Jan 2023, 15:16
- Role
- EVP & General Counsel
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 15 Dec 2022
- Transactions
- 6
- Transaction value
- -$3,369,960
- Accepted by SEC
- 16 Dec 2022, 15:14
- Role
- EVP & General Counsel
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 28 Jun 2022
- Transactions
- 9
- Transaction value
- -$4,671,733
- Accepted by SEC
- 30 Jun 2022, 17:00
- Role
- EVP & General Counsel
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 01 Apr 2022
- Transactions
- 3
- Transaction value
- -$6,331,570
- Accepted by SEC
- 05 Apr 2022, 19:39
- Role
- EVP & General Counsel
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 15 Mar 2022
- Transactions
- 3
- Transaction value
- -$140,729
- Accepted by SEC
- 17 Mar 2022, 16:32
- Role
- EVP & General Counsel
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 21 Feb 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 23 Feb 2022, 15:30
- Role
- EVP & General Counsel
- Next action
- Open filing details
4
CVS
CVS HEALTH Corp
- Report period
- 10 May 2021
- Transactions
- 3
- Transaction value
- -$2,604,268
- Accepted by SEC
- 12 May 2021, 17:30
- Role
- EVP & General Counsel
- Next action
- Open filing details